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Case presentation
DR. BRYAN BOHMAN (Resident in Medicine, Stanford University
School of Medicine, Stanford, California): A 68-year-old man was
referred to Stanford University Medical Center on January 13 for
extreme thirst and polyuria of approximately 2 months' duration. He
had smoked 2 packs of cigarettes daily for 50 years and had a chronic,
productive cough. For many years he had taken 25 mg/day of hydro-
chlorothiazide for hypertension. Two months before admission, on
November 24 at approximately 2:00 P.M., the sudden onset of extreme
polydipsia compelled him to slake his thirst with cold water as well as
with Coca-Cola, which he usually did not drink. Associated with the
thirst were polyuria and nocturia, which caused him to urinate an
average of 10 times per night at half-hour intervals. Two and one-half
weeks prior to admission, on December 27, he was admitted to another
hospital for 5 days, where he underwent 2 fluid deprivation tests, each
lasting 12 hours. He continued to urinate copiously during those tests,
excreting 3 to 5 liters of urine. At the end of the first fluid deprivation
test, the urine osmolality was 118 m0sm/kg H20; after 5 units of
Pitressin was administered subcutaneously, the urine osmolality in-
creased to 180 m0sin/kg 1120. The entire test was repeated with similar
results, 169 and 240 m0sm/kg H20, respectively.
An intravenous pyelogram showed an enlarged prostate and the
possibility of "partial distal ureteral obstructions causing functional
stasis and calyceal blunting." Skull films showed the sella to be normal
in size with well-delineated borders. The serum sodium concentration
Presentation of the Forum is made possible by grants from Smith
Kline & French Laboratories, CIBA Pharmaceutical Company,
and GEIGY Pharmaceuticals.
© 1983 by the International Society of Nephrology
was 145 mEq/liter; potassium, 4.2 mEq/liter; chloride, Ill mEq/liter;
and bicarbonate, 28 mEq/liter. The patient was treated with chlorprop-
amide and was discharged. Because no effect was noted, he resumed
taking hydrochiorothiazide, which also had no effect; his polydipsia,
polyuria, and cough continued. Ten days prior to admission, he
experienced dyspnea, chills, intermittent fevers up to 37.8°C, anorexia,
nausea without vomiting, bifrontal headaches (especially in the left
retroorbital area), and weakness. These symptoms progressively in-
creased. He took 4 aspirin tablets every 6 hours. Three days prior to
admission, he became light-headed without having vertigo. He fell,
striking the right side of his chest and head, but he did not lose
consciousness. Orthostatic lightheadedness continued. His left eyelid
began to droop. The day after he fell, a chest film revealed elevation of
the left diaphragm, atelectatic streaks at the base, and a mass in the left
hilum, all of which were thought to be new findings when compared
with a routine chest film taken 4 months earlier. He was referred to
Stanford University Medical Center.
The patient had had skin cancers excised many years previously.
Two kidney stones were removed when he was 57; there was no
recurrence. His hypertension was mild and had no known sequelae. He
drank 4 to 6 ounces of alcohol per day. He took 0.5 g of meprobamate
and 25 mg of amitriptyline daily for "nerves." There was no family
history of renal disease. He was known to have had an enlarged
prostate for 8 years.
On physical examination, the patient was a mildly obese, somewhat
weak man appearing his stated age. The blood pressure was 104/86 mm
Hg supine and 96/84 mm Hg sitting. The pulse rose from 100 supine to
104 beats/mm with sitting. The respiratory rate was 16/mm and the
temperature was 37.9°C. A healed laceration and an old contusion were
visible over the left forehead. Left ptosis was evident. The extraocular
movements and visual fields were normal. Breath sounds were de-
creased at the left base. Neurologic examination revealed a broad-based
gait. The patient had trouble performing the heel-to-toe maneuver.
Motor and sensory examinations were otherwise normal.
Laboratory examination revealed: hematocrit, 44%; hemoglobin,
15.2 gldl; white blood cell count, 8400 mm3 with 7% eosinophils. The
serum sodium concentration was 131 mEq/liter; potassium, 3.5 mEq/liter;
chloride, 93 mEq/liter; and bicarbonate, 22 mEq/liter. The glucose was
93 mg/dI; creatinine, 1.3 mg/dl; BUN, 15 mg/dl; uric acid, 8.1 mgldl;
calcium, 9.7 mg/dl; phosphate, 3.4 mg/dl; and cholesterol, 181 mg/dl.
The total protein was 7 and the albumin 4 g/dl. Alkaline phosphatase
was 160 units (normal range, 30 to 115). Lactic dehydrogenase was 496
U/mI (normal range, 60 to 200). The serum glutamic oxalacetic transam-
inase was 28 units (normal, less than 42). The urinary specific gravity
was 1.008; urine osmolality was 273 m0sm/kg H20. The pH was 6; tests
for glucose and protein were negative. The urine sediment revealed Ito
5 white cells and no red cells per high-power field. No casts were
present. A chest film was taken.
Some parameters of the patient's course are illustrated in Figure 1.
Low-grade fever and slight hypotension persisted. The patient com-
plained of nausea and malaise and became hoarse. A CT scan revealed a
pituitary mass. Endocrine function test results are shown in Table I.
Because of the possibility of anterior pituitary insufficiency, perform-
ing a water deprivation test without first administering corticoste,-oids
was deemed unsafe; hence, the patient was treated with 40 mg of
prednisone daily. He improved dramatically. Urine output, however,
increased from 2 to 3 liters to 6 to 7 liters per day, and the urine
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Fig. 1. Patients course. Four hospitalizations at Stanford University
Medical Center, corresponding to the numbered brackets at the top of
the figure, are summarized. Intake and output are expressed in liters;
PNa is the plasma sodium concentration in mEq/liter; PO,m and U0,, are
the plasma and urine osmolality, respectively, in mOsm/kg water, and
U50 is the urine specific gravity. The patient was first admitted on
1/13. Treatment with prednisone was begun 1/16, marked by the vertical
dashed line, and later changed to cortisone as indicated by the upper
continuous horizontal line labeled "Cortisone" in the top panel. The
other horizontal line in the top panel indicates that DDAVP was begun
the day before discharge and except for a temporary discontinuation to
correct acute hyponatremia during the second hospitalization, was
administered daily thereafter. The horizontal dotted lines in the 4th and
5th panels from the top indicate normal values for PNa and P0,,,,
respectively. The individual points in the bottom panel indicate when
Us0 was determined. Note the roughly parallel rises in intake, output,
PNa, and Po coincident with the initiation of cortisone (prednisone)
therapy.
osmolality decreased to 93 mOsm/kg H20; the serum sodium concen-
tration rose to 138 mEq/liter. A water deprivation test was performed
on the eighth hospital day; the results are illustrated in Figure 2. The
patient subsequently was treated with multiple hormone replacement:
levothyroxine sodium, 0.1 mg/day; hydrocortisone, 20mg each morning
and 10 mg each afternoon; and deamino D-arginine vasopressin
(DDAVP), 7.5 pg/day. The signs and symptoms of diabetes insipidus
promptly resolved.
The patient underwent bronchoscopy twice. Multiple biopsies of the
bronchial tree were negative. Brushings from the second bronchosco-
py, however, yielded cells from an undifferentiated carcinoma. A left
supraclavicular node biopsy also revealed a poorly differentiated
carcinoma.
The patient was discharged 10 days after admission with the diagnosis
of panhypopituitarism due to metastatic carcinoma probably originating
Table 1. Results of endocrine function tests
Test Patient Normal range
Plasma cortisol at 7 AM. 2 sg/ml 5—25 sg/m1
Plasma cortisol at 4 P.M. 2 rg/ml 2—8 tg/ml
Thyroxine 0.5 tg/ml 0.8—2.3 ig/ml
Thyroxine (radioimmunoassay) 2.6 sg/ml 4.7—10.7 g/m1
Thyroid-stimulating hormone <2 1U/ml <10 U/ml
Testosterone <25 ng/dl 280—1200 ng/dl
Luteinizing hormone 10 mU/mi 4—8 mU/mI
in the lung. Discharge medications included 7.5 g of DDAVP per day
as well as hydrocortisone, thyroxine, testosterone, and ibuprofen.
Radiation therapy to the chest, brain, and sella was begun.
The patient was readmitted to the hospital one week after discharge
complaining of increasing headache and back pain that had begun a few
days earlier. The physical examination was unchanged except for the
observation of partial paralysis of the left third cranial nerve with a
decreased ability to depress, elevate, and adduct the left eye. The pupils
were normal. Positive snout and grasp reflexes were noted. Treatment
with dexamethasone was begun. A myelogram showed no evidence of
cord compression or metastasis to the spinal cord. The headaches were
thought to be the consequence of cranial irradiation.
While in the hospital, the patient suddenly developed dysphasia,
which was attributed to a fall in the serum sodium concentration to 123
mEq/liter. After a temporary discontinuation of the DDAVP, the urine
output increased, the serum sodium concentration rose to 138 mEq/
liter, and the dysphasia rapidly disappeared. He was discharged 5 days
after admission.
The patient was hospitalized twice more, February 26 to March 3 and
March 10 to March 18, for severe gastrointestinal bleeding thought to be
due to peptic ulcerations near the esophagogastric junction and to
Candida esophageal ulcers. He was given palliative treatment and
discharged to a nursing home on March 18. He died 6 days later. An
autopsy was not performed.
Discussion
DR. REX L. JAMISON (Professor of Medicine and Chief,
Division of Nephrology, Stanford University School of Medi-
cine, Stanford, California): Let us begin by reviewing the x-ray
films.
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DR. WILLIAM H. MARSHALL, JR. (Professor of Radiology
(Clinical), Stanford University School of Medicine): A chest
film taken at another hospital 3 months before the patient's first
admission to Stanford showed a small mass in the left anterior
hemithorax. In the interval, the mass underwent remarkable
enlargement and formed a large rounded volume (Fig. 3). We
can see an associated elevation of the left hemidiaphragm.
A CT scan of the sella region utilizing thin-section (high-
resolution) technique and presented in a lateral projection (Fig.
4) shows an expansive lesion overfilling the sella and involving
the distal infundibulum. The images establish a metastasis or
metastases involving the hypophyseal infundibulum and the
pituitary gland.
DR. JAMISON: In summary, this unfortunate man developed
lung cancer that by the time of discovery had metastasized to
the pituitary. Growth of the metastasis led to numerous compli-
cations, beginning with diabetes insipidus and followed by
manifestations of anterior hypopituitarism. The cancer spread;
he developed hemorrhagic gastrointestinal ulcerations and died
only 4 months after the first sign of illness. Although in the long
run attempts at retarding the growth and spread of his devastat-
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Fig. 2. Results of water deprivation test. Water was withheld beginning
at 0 hour. The weight declined 4 kg (top graph). Plasma sodium
concentration (PNa) rose from 145 to 153 mEq/liter (middle graph). In
lowest graph, the heavy black line shows the patient's urine osmolality
(left ordinate) and specific gravity (right ordinate). Responses charac-
teristic of patients with various causes of polyuria are shown in lighter
lines: polydipsia, continuous line; partial diabetes insipidus, dash-dot-
dash line; complete diabetes insipidus, dashed line that rises after
antidiuretic hormone (ADH-vertical arrow) is given; nephrogenic diabe-
tes insipidus, lower dashed line that fails to rise (adapted from Valtin
[5]). Just before ADH was given, blood was obtained for arginine
vasopressin (AVP) concentration, which was below the lowest detect-
able level of 0.9 pg/ml (top right-hand portion of figure).
ing malignancy became the main goal, an overriding initial
concern was the remarkable abnormality in water balance that
the patient exhibited. I wish to focus on these disturbances, for
they serve as a catechism of the regulation of water balance and
the consequences of disorders thereof. I hope to clarify: (I) the
cause of the patient's polyuria; (2) why in the presence of
polyuria he paradoxically developed hyponatremia during the
first Stanford Hospital admission; and (3) the role of adrenal
cortical hormones in urinary dilution.
Since the classic studies of Fisher, Ingram, and Ranson [1]
and of Verney [2], it has been recognized that the neurohypoph-
ysis plays a fundamental role in controlling volume and tonicity
of body water in combination with the thirst mechanism, as
elucidated by Andersson and McCann [3]. Leaf referred to this
mechanism as a double-negative feedback system [4]. Cell
membranes are so permeable to water that the effective osmo-
lality throughout all fluid compartments in the body is the same.
Thus the tonicity of cell water and of the cell volume as well as
the tonicity and volume of extracellular water are regulated by
the double-negative feedback arrangement, an extremely sensi-
tive and precise governor. The "redundancy" of the system
ensures that even if the pituitary does not release sufficient
quantities of antidiuretic hormone or if the kidney cannot
respond to antidiuretic hormone, thirst will induce a compensa-
tory increase in water intake. If antidiuretic hormone is released
inappropriately or if the kidneys otherwise are unable to excrete
a water load, thirst normally diminishes, thereby blunting the
hyponatremia. Disturbances in urinary concentrating and dilut-
ing ability, unless severe, more often lead to marked changes in
volume and composition of body fluid when these alterations
either are coupled with a concomitant derangement of the thirst
center or with an inability of the patient to communicate thirst.
Individuals at the extreme ends of the age spectrum—infants
and confused elderly patients—are most vulnerable because
they cannot signal their thirst.
What was the cause of the polyuria in the patient under
discussion today? Two simple tests usually can answer this
question. In the presence of an adequate physiologic stimulus,
does the kidney concentrate urine? If not, does the kidney
respond in the presence of antidiuretic hormone? The various
renal responses characteristic of disorders causing polyuria are
illustrated on the lower portion of Figure 2, which closely
resembles an illustration in Valtin's textbook [5]. Superimposed
in heavy black line is this patient's urinary response. The
ordinate on the left is urine osmolality in milliosmoles per
kilogram water, and the one on the right is specific gravity, a
measurement that is very useful in the absence of the more
precise determination of osmolality. At time zero, water intake
is stopped. Individuals who have polyuria because they drink
too much water follow the upper curve; the urine osmolality
rises as release of endogenous antidiuretic hormone is stimulat-
ed. Because the endogenous hormone supply is adequate,
subsequent administration of exogenous antidiuretic hormone
does not further increase urinary osmolality. Patients with
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Fig. 3. Chest film taken on admission to Stanford. A large mass was
present in the left hemithorax. The left hemidiaphragm is elevated.
Fig. 4. Computer-assisted tomographic scan of the sella region (lateral
projection). Anterior (A) is to the left. The white areas are bone or
cross-sections of arteries. The arrow points to a lesion overfilling the
sella and involving the distal infundibulum (lighter density).
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nephrogenic diabetes insipidus, that is, individuals whose kid-
neys cannot respond to antidiuretic hormone, continue to
excrete a dilute urine and do not respond even to supramaximal
doses of antidiuretic hormone, as illustrated by the lowest line
in Figure 2.
Problems in diagnosis arise when the pattern of response falls
between these extremes, for example, in patients with partial
diabetes insipidus (that is, those not completely devoid of
antidiuretic hormone). In this case, urine osmolality rises, al-
most always exceeding the serum osmolality, until the limited
endogenous supply of antidiuretic hormone is exhausted [6].
Subsequent administration of exogenous vasopressin augments
the inadequate endogenous hormone, causing urine osmolality
to rise still further.
In a patient totally lacking antidiuretic hormone (complete
diabetes insipidus), urine osmolality remains essentially un-
changed during water deprivation, as it does in patients with
nephrogenic diabetes insipidus. If, however, water deprivation
and the ensuing hyperosmolality are extended beyond the point
normally required to stimulate antidiuretic hormone production
maximally, blood pressure may fall. Under such a circum-
stance, urine osmolality can rise to 300 to 400 mOsm/kg H20
even in the absence of antidiuretic hormone; we shall return to
this phenomenon later. It is essential that one proceed to the
second step of the test before circulatory instability occurs.
When exogenous antidiuretic hormone is given, urine osmolali-
ty rises strikingly in a patient with neurogenic diabetes insipi-
dus. In all these different causes of polyuria, the urine osmolali-
ty achieved in the presence of exogenous antidiuretic hormone
is much less than the normal maximum after prolonged dehy-
dration (1200 mOsm/kg H20, approximately equivalent to a
specific gravity of 1.040), because the interstitium of the renal
medulla in polyuric conditions is less hyperosmotic than in
normal antidiuresis [7].
Let us now examine this patient's response (Fig. 2). At 6P.M.
on January 19, water deprivation began and continued for 18
hours. The patient remained polyuric and by noon on January
20 had excreted 4 liters of urine and, correspondingly, had lost 4
kg in weight. The agreement between urine volume and weight
loss shows good internal consistency. There was some variabili-
ty in the serum sodium concentration, but the trend is unmistak-
able, and the last value, 153 mEq/liter, is quite high. The
corresponding serum osmolality (not shown) was 315 mOsm/kg
H20. Clearly the stimulus for release of antidiuretic hormone
was adequate; yet urine osmolality remained very low at 100
mOsm/kg H20. The diagnosis of primary polydipsia was thus
excluded. Either the patient lacked antidiuretic hormone or his
kidneys were unable to respond to the hormone. He was then
given 5 units of Pitressin subcutaneously. Thirty minutes later,
the urine osmolality rose to 148 mOsmlkg H20; at one hour it
increased further to 200 mOsm/kg H20. But no further rise in
osmolality was recorded; in fact, the test was stopped shortly
thereafter. The patient was allowed to drink water and he
quickly restored his water deficit. Specific gravity measured
hours later on the same day was only 1.005.
The initial response to antidiuretic hormone was what one
would predict for a patient with neurogenic rather than nephro-
genic diabetes insipidus, but the response was not definitive
because the urine osmolality did not continue to rise along the
curve described by the dashed line in Figure 2. In fact, the
response duplicated that which had occurred twice previously
in another hospital. Yet the test was interpreted—correctly as it
turned out—as demonstrating neurogenic diabetes insipidus.
How do we know the diagnosis was correct? First, a radio-
immunoassay for arginine vasopressin performed at the end of
the water-deprivation test indicated that the AVP level in the
plasma was below the lowest detectable limit, 0.9 pg/mI,
Second, after DDAVP treatment was begun, the specific gravi-
ty was found several times to be 1.015, indicating a concentrat-
ed urine and a good response to antidiuretic hormone treat-
ment. Why then was the initial urinary response to exogenous
vasopressin so modest? We will return to this question later.
Fisher and colleagues demonstrated that axons of neurons
whose cell bodies reside in the supraoptic and paraventricular
nuclei of the hypothalamus pass through the pituitary stalk to
end in the posterior pituitary [11. They found that at least 90% of
the posterior pituitary must be ablated to cause diabetes insipi-
dus and that even then the condition is only temporary until the
hormone produced in nerve cells in the hypothalamus re-enters
the circulation. If a lesion occurs in the supraoptic-hypophyseal
tract above the stalk, however, permanent diabetes insipidus is
established. The location of the metastatic tumor above the
sella in this patient conforms to their dictum (Fig. 4).
After the diagnosis was made, the patient was treated with
DDAVP, a synthetic analogue of the naturally occurring hor-
mone with a very high antidiuretic-to-pressor potency. The
analogue was very effective in this patient, reducing urine flow
to less than 2 liters/day. But the potential hazard of hyponatre-
mia exists with the use of vasopressin, as this patient's course
illustrates. His serum sodium level decreased to 123 mEq/liter;
simultaneously he developed acute dysphasia. The DDAVP
was discontinued, urine flow rose, and the serum sodium
concentration returned to normal. His speech disorder disap-
peared. These events caused a neurologist to speculate that the
dysphasia might have been due to hyponatremia-induced cell
swelling of metastatic foci in the area of the brain controlling
speech. The suggestion is intriguing.
Another mechanism is required to explain the earlier episode
of hyponatremia present at the time of the first Stanford
Hospital admission; hyponatremia in a patient lacking antidi-
uretic hormone is, of course, a paradoxical finding. The patient
was shown to have anterior pituitary insufficiency and adreno-
cortical insufficiency. In particular, the plasma cortisol level
was very low. Administration of prednisone clearly unmasked
the underlying diabetes insipidus and corrected the hyponatre-
mia (Fig. 1). The patient had no evidence of mineralocorticoid
deficiency. For example, the serum potassium concentration
was 3.5 mEq/liter. Indeed, the renin-angiotensin-aldosterone
axis is known to function normally despite the absence of
ACTH [8]. In view of the evidence for panhypopituitarism, the
low plasma cortisol, and the effect of prednisone, we can
reasonably attribute the earlier episode of hyponatremia to
adrenal cortical insufficiency secondary to anterior hypopituita-
rism, and specifically to insufficient cortisol, the physiologic
glucocorticoid.
To understand why cortisol deficiency impairs the ability to
excrete a dilute urine, it is useful to review briefly the mecha-
nism of urinary dilution. Normally 50% to 60% of filtered
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sodium and 65% to 75% of filtered water are reabsorbed by the
proximal convoluted tubule and pars recta. The remainder, a
hyperosmotic fluid containing proportionally more sodium than
water, is delivered to the ascending limb, commonly called the
"diluting segment." In this segment, 40% to 45% of the filtered
sodium (or approximately 85% of the sodium chloride delivered
to the ascending limb) is reabsorbed. Since the epithelium is
water impermeable, no water is reabsorbed despite the pres-
ence of the hypertonic medullary interstitium. This is important
for several reasons. First, the same transport mechanism re-
sponsible for providing the "single effect" that is augmented by
countercurrent flow to establish the axial osmotic gradient in
the medulla, and hence responsible for urinary concentration, is
also primarily responsible for urinary dilution—an elegant ex-
ample of biologic economy, as described recently by Berliner
[9]. Second, fluid entering the distal and cortical collecting
tubule is rendered markedly hypoosmotic, reaching values as
low as 100 mOsm/kg H20. Third, only 5% to 10% of the filtered
sodium chloride remains; this means that, despite their limited
reabsorptive capacity, the distal and collecting tubules are
adequate to reclaim all the sodium left if necessary.
It is generally held that in the absence of ADH, the distal and
collecting tubules are impermeable to water. If that were so,
urinary excretion of water in patients with diabetes insipidus
would equal at least 25% of the GFR—or 30 ml/min in an adult
male—approximately 43 liters per day [10]. In fact, such
patients rarely excrete one-half that much. We now understand
why. Although the osmotic water permeability of the distal and
collecting tubule is low, it is not zero. Furthermore, large
transepithelial osmotic gradients develop across the distal tu-
bule and the cortical, outer medullary, and especially the inner
medullary segments of the collecting duct in water diuresis. As
a consequence, approximately 10% of the filtered water is
reabsorbed across these segments and the remaining 15% is
excreted [10]. In fact, the volume of water reabsorbed by the
collecting duct in the inner medulla is greater in water diuresis
than it is in antidiuresis [10]. Moreover, one can readily
appreciate that, given a finite water permeability of the tubule
epithelium, a reduction in tubule fluid flow to the distal and
collecting tubule will result in an increase in the proportion of
water reabsorbed and therefore will cause an increase in the
osmolality of the unreabsorbed fluid, providing solute does not
accompany the reabsorbed water. Given this continued water
reabsorption, one might expect that the osmolality of tubule
fluid should rise from its minimum value at the end of the
ascending limb to a higher value in the final urine by a factor of
25/15, where 25% is the approximate fraction of filtered water at
the end of the ascending limb and 15% is the approximate
fractional excretion of water usually observed in patients with
diabetes insipidus. Yet we know that in these circumstances
urine is extremely dilute. In this patient, urine osmolality was as
low as 96 mOsm/kg H20, and values as low as 50 mOsm/kg H20
are not uncommon [10]. The average minimum osmolality
achieved in fluid at the end of the cortical thick ascending limb
(100 mOsmlkg H20) is not even as low as this latter value. We
are compelled to conclude, therefore, that solute in excess of
water also must be reabsorbed by the renal tubule beyond the
ascending limb. Indeed, experiments have verified that as much
as 5% of the filtered sodium is reabsorbed by the collecting duct
in water diuresis [11]. The reabsorption of sodium and an
accompanying anion not only ensures the maintenance of the
low tubule fluid osmolality, it lowers the osmolality even
further. Thus the collecting duct plays a role in urinary dilution.
This diluting effect of course would be dissipated if the osmotic
water permeability of the collecting tubule were increased by
ADH or other means, or if sodium chloride reabsorption were
reduced.
In summary, the key elements required for forming and
excreting dilute urine are: (1) delivery of adequate amounts of
sodium chloride and water to the ascending limb; (2) reabsorp-
tion of sodium chloride by the diluting segment, primarily the
ascending limb but also the collecting tubule; and (3) very low
osmotic water permeability of the ascending limb, distal tubule,
and collecting duct. Against this framework, how does adrenal
insufficiency impair urinary dilution? The long-lasting contro-
versy surrounding this question is on its way to being settled by
the use of new techniques. The answer emerging seems to be
that almost everyone was partly right [12].
Mineralocorticoid deficiency. The classic studies by Loeb,
Han-op, and colleagues revealed that a major consequence of
adrenocorticoid insufficiency is urinary sodium loss [13, 14];
indeed, the potency of a corticosteroid in causing sodium
retention compared to its potency in inducing glycogen deposi-
tion is the traditional way to differentiate mineralocorticoid
from glucocorticoid action. We know that aldosterone attaches
to receptors in the collecting duct and stimulates sodium
reabsorption and that the mechanism involves activation of
sodium-potassium ATPase [15, 16]. Two consequences of mm-
eralocorticoid deficiency are immediately predictable: sodium
and water delivery to the diluting segment will be reduced
secondary to the fall in GFR as a sequela of salt depletion, and
urinary dilution in the collecting duct will be impaired owing to
reduced sodium chloride reabsorption by that segment. Evi-
dence for both the first [17] and the second [18] effect has been
reported. There is a third way in which mineralocorticoid
deficiency diminishes urinary dilution: sodium deficiency acts
as a nonosmotic stimulus to vasopressin release [121. As noted,
however, this patient presumably did not have a deficiency of
mineralocorticoid and he was not sodium depleted. His defect
in water excretion therefore must have been caused by insuffi-
cient glucocorticoid.
Glucocorticoid deficiency. It is well known that adrenalecto-
mized animals given physiologic replacement of mineralocor-
ticoid still develop impaired water excretion, usually after an
interval varying between one and several days, depending on
the species. This deficiency can be corrected by the administra-
tion of physiologic doses of glucocorticoid [19]. The mechanism
by which glucocorticoid deficiency leads to impaired urinary
dilution, however, is complicated.
It is now clear that both ADH-dependent and ADH-indepen-
dent pathways are involved [121. Thanks to Robertson's devel-
opment of a specific radioimmunoassay for vasopressin [20], we
know that ADH plays an important role in impaired water
excretion in some patients with adrenal glucocorticoid deficien-
cy. It was demonstrated that in the glucocorticoid-deficient
dog, vasopressin levels rose despite the hypoosmolality of the
plasma and thus prevented the excretion of a maximally dilute
urine [19]. The rise in vasopressin was thought to be due either
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to impaired cardiac function, as shown by a reduced stroke
volume and cardiac output (which became evident after a water
load), or to reduced blood pressure. In other words, there was a
nonosmotic stimulation of ADH release through a diminution in
"effective" circulating blood volume [19].
Today's patient, however, unequivocally demonstrates that
glucocorticoid deficiency must impair urinary diluting ability by
an ADH-independent pathway because, at the time of his first
episode of hyponatremia, there was presumably no arginine
vasopressin in his blood stream. The evidence is convincing
that he had had diabetes insipidus for more than a month before
coming to Stanford, and shortly after admission, the plasma
vasopressin was undetectable after 18 hours of water
deprivation.
Studies as far back as the turn of the century strongly support
the view that glucocorticoid deficiency impairs urinary diluting
ability through an ADH-independent mechanism. As early as
1918 it was recognized that if the anterior lobe of the pituitary is
destroyed, manifestations of diabetes insipidus may be abol-
ished [21—231. Indeed, Martin showed that patients with under-
lying but unrecognized diabetes insipidus manifest the classic
findings only after receiving ACTH or cortisone [24]. Agus and
Goldberg demonstrated that impaired water excretion in pa-
tients with anterior hypopituitarism could be improved with the
administration of physiologic doses of hydrocortisone [25].
To clarify why adrenal insufficiency impairs urinary dilution
in the absence of antidiuretic hormone, Green, Harrington, and
Valtin investigated the response to water load in Brattleboro
rats, animals with hereditary hypothalamic diabetes insipidus
[18]. After adrenalectomy, the rats were studied before and
after mineralocorticoid or glucocorticoid replacement. Replace-
ment of glucocorticoid alone fully restored the rats' capacity to
excrete a water load but not their ability to maximally dilute the
urine. Replacement of mineralocorticoid alone completely re-
stored the diluting ability (as previously mentioned), but not
their capacity to excrete the water load; replacement of both
steroids normalized both responses.
As reported by Stolte and coworkers and by Hierholzer and
Wiederholt, the rate of transtubular efflux of water from a
hypotonic perfusate injected into a segment of distal tubule
increased in the absence of adrenal steroid; the increase was
reversed by glucocorticoid replacement [26, 27]. These authors
concluded that glucocorticoid deficiency somehow causes an
abnormal increase in the water permeability of the distal tubule.
These experiments were performed in rats with intact pituitary
glands, so one might argue that this effect was mediated by
vasopressin. But the water permeability of the distal tubule in
the adrenalectomized rat was significantly higher than that in
the normal antidiuretic rat, whose levels of circulating antidi-
uretic hormone are presumably maximal; therefore the effect of
glucocorticoid deficiency was additive to the effect of antidi-
uretic hormone. In the absence of antidiuretic hormone or
cyclic AMP, neither mineralocorticoid nor glucocorticoid af-
fected osmotic water permeability of the toad bladder studied in
vitro [281; this finding militates against a specific water perme-
ability-enhancing effect of the lack of glucocorticoid on the
distal tubule. Kurokawa et al discovered elevated cyclic AMP
concentrations in isolated medullary tubules from adrenalecto-
mized rats [29]; the water permeability of medullary collecting
tubules therefore might be increased independently of antidi-
uretic hormone. Schwartz and Kokko studied isolated perfused
cortical collecting tubules removed from rabbits adrenalecto-
mized 10 days earlier [30]. In the absence of antidiuretic
hormone, the tubules did not have an increased permeability to
osmotic-induced water flow. Rayson, Roy, and Morgan showed
that water permeability of the medullary collecting duct in
adrenalectomized rats was not increased either [31]. Although
the issue is not settled, it does not appear that deficiency of
glucocorticoid increases water permeability of the distal or
collecting tubule.
Boykin et al demonstrated that glucocorticoid deficiency has
a deleterious effect on cardiac function; the disordered cardiac
function in turn stimulates release of antidiuretic hormone,
probably by a baroreceptor-mediated pathway, and thereby
impairs water excretion [19]. Of course, this observation does
not imply that a reduced effective circulating blood volume
cannot also impair water excretion by an ADH-independent
pathway. Linas and coworkers found that rats with intact
pituitary glands had an impaired ability to excrete water and to
dilute urine after one day of glucocorticoid deficiency; 2 weeks
without glucocorticoid produced considerably more impairment
[32]. In glucocorticoid-deficient Brattleboro rats, excretion of
an acute water load was normal after one day but was reduced
after 2 weeks of glucocorticoid depletion, as was urinary
diluting ability, It was proposed that the ADH-independent
pathway by which urinary dilution was impaired was secondary
to reduced cardiac output, which decreased renal blood flow
and GFR and increased proximal reabsorption. Consequently,
less salt and water reached the diluting site [32].
Edwards, Gellai, and Valtin showed that small changes in the
renal circulation can dramatically impair urinary diluting ability
[33]. Using awake Brattleboro rats with intact adrenal glands,
these investigators installed a cuff around the aorta above the
renal arteries. As shown in Figure 5, the cuff was inflated just
enough to lower mean arterial pressure below the cuff from 107
to 87 mm Hg. Renal plasma flow decreased from 3.9 to 3.1 ml!
min/100 g body weight (not shown), and GFR declined very
slightly, 0.90 to 0.86 ml/min!100 g body weight. Urine osmolali-
ty increased from 125 to 309 mOsm/kg H20, and urine flow
decreased from 86 to 22 ml/min/100 g body weight. These
animals lack antidiuretic hormone; therefore the antidiuretic
mechanism clearly proceeds via a pathway independent of the
hormone. Edwards et a! suggested that in addition to decreased
salt and water delivery to the loop of Henle, other factors may
play a role, including decreased axial flow of fluid along the
collecting duct and greater efficiency of the countercurrent
exchange (due to decreased medullary blood flow). Suppose the
experiment had been performed in the reverse. Release of the
cuff to raise the mean arterial pressure 20 mm Hg would have
caused a striking increase in urine flow and would have
decreased the urine osmolality, whereas the mean GFR would
have increased only 5%.
Evidence obtained in the manner just described suggests that
glucocorticoid deficiency can impair urinary diluting ability by a
pathway independent of ADH. Let us examine this suggestion
in today's patient (Fig. 6). After the administration of predni-
sone, there was a subtle but unmistakable increase in blood
pressure and with it a slight fall in the concentration of serum
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Fig. S. Effect of partial Constriction by cuff of the aorta above the renal
arteries in conscious Brattleboro rats. The abscissa is time in minutes.
At the arrow the cuff was inflated, thus producing a lower mean arterial
pressure distal to cuff from 107 to 87 mm Hg (top panel). Average GFR
(second panel) declined only 4% from 900 to 860 dImin/l00 g body wt.
The effects on urine flow (third panel) and urine osmolality (fourth
panel), in contrast, were dramatic. The vertical bars indicate
standard error. Adapted from Edwards et at [33] and the American
Journal of Physiology, by permission.
Date 13 14 15 16 17 18 19 20 21 22 23
Prednisone I I I I I
DDAVP
Creatinine 1.3 1.1 1.3
BUN 15 9 11
:
UOSM 273 116 93 110
Fig. 6. First hospital admission. In the upper panel, treatment with
prednisone was started January 16, as indicated by the upper horizontal
line. DDAVP therapy was begun January 20 (lower horizontal line). The
numbers indicate the concentrations of plasma creatinine and BUN,
respectively (mgldl). The line connecting the dots is the plasma sodium
concentration (PNa) in mEq/liter. In the lower panel, the lines indicate
systolic and diastolic pressures, respectively, in mm Hg. Values for
urine osmolality (U0,) are given in mOsm/kg H20. Note the upward
trend in blood pressure after prednisone was begun. Urine flow
increased (not shown), the urine became more dilute, and PNa rose.
creatinine and BUN; these latter changes indicated a small
increase in GFR. Associated with these alterations, urine flow
increased and urine osmolality fell. One can reasonably con-
clude that this patient's impaired capacity to excrete water was
due to a reduced cardiac output secondary to glucocorticoid
deficiency, which exerted its effect through an ADH-indepen-
dent pathway.
Why did the patient initially have a poor response to antidi-
uretic hormone? After administration of antidiuretic hormone,
the initial rise in urine osmolality was relatively unimpressive.
Since the water-deprivation test was performed in the presence
of adequate glucocorticoid and mineralocorticoid (Fig. 2), why
was the patient's renal response to vasopressin so modest? The
referring physician was asked to forward films of the intrave-
nous pyelogram (IVP), which had been performed at another
hospital (Fig. 7). Figure 7A shows the preliminary film. It is
obvious that the patient had a large urinary bladder. Midway
through the IVP one can see that the ureters are dilated
bilaterally and the calyces are indistinct (Fig. 7B), but these
findings are consistent with the sustained high urine flow that
the patient had experienced for approximately one month
before undergoing the IVP. Note the presence of a large
prostate in Figure 7C. Figure 7D shows the postvoid film. The
patient did not empty his bladder well. I do not infer from these
films that he had a high-grade prostatic obstruction; other tests
would have to be done to establish that diagnosis. But the films
do strongly suggest that the patient had a bladder of large
capacity that did not empty completely. During the water-
deprivation tests, the bladder was continuously filling. After
administration of vasopressin, the patient was asked to void
twice at 30-minute intervals. These urine samples were proba-
bly a mixture of very dilute urine formed before, and concen-
trated urine formed after, the administration of ADH. If water
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Fig. 7. Intravenous pyelogram performed in late December. A Prelimi-
nary film. Note the large urinary bladder. B Midway through the IVP.
The calyces are indistinct and the ureters are dilated. C Before voiding.
Note the large prostate. D After voiding. Bladder emptying is poor.
It
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had been withheld another hour and additional urine samples
had been obtained, or if the patient had been catheterized to
ensure that his bladder was empty before administration of
ADH, I think the osmolality of the urine samples would have
been higher, that is, above 300 mOsm/kg H20.
Summary. Lung cancer developed in this patient sometime
well before his admission to Stanford; the cancer metastasized
to the hypothalamus and pituitary. The metastatic focus grew
until the stalk was interrupted; when antidiuretic hormone
disappeared from his circulation, on November 24 at 2 P.M., he
experienced the sudden onset of massive polyuria, which
created intense thirst. He subsequently developed signs and
symptoms of anterior pituitary insufficiency. The secondary
deficiency of cortisol compromised cardiac output, and renal
blood flow declined. As a consequence of diminished salt and
water delivery to the diluting site in the renal tubule, and also as
a result of decreased axial flow of fluid along the collecting duct,
urinary diluting ability was impaired and dilutional hyponatre-
mia ensued notwithstanding the absence of antidiuretic hor-
mone. The reemergence of copious flow of dilute urine follow-
ing treatment with prednisone indicated that the hyponatremia
was due to a lack of adrenal cortical hormone. Despite an
adequate osmotic stimulus during the water-deprivation test,
urine osmolality failed to increase because of the lack of
endogenous antidiuretic hormone. The patient's poor response
to exogenous antidiuretic hormone likely was due to his inabil-
ity to completely empty his large urinary bladder. Subsequent
treatment with DDAVP was effective and enabled the physi-
cians to devote their full attention to attempts at palliating the
underlying disease.
Questions and answers
DR. ARNOLD BERNS (Attending Physician, Michael Reese
Hospital, Chicago): What effect do you think this patient's
thyroxine deficiency had on his urinary diluting ability?
DR. JAMIs0N: Hypothyroidism can certainly compromise a
patient's ability to excrete a dilute urine, primarily because of a
decreased GFR that results in decreased delivery of salt and
water to the diluting site [7, 34]. There is also evidence for
nonosmotic stimulation of antidiuretic hormone release [35]. I
don't think hypopituitarism was a factor in the impaired urinary
dilution in this patient because he was able to dilute the urine
maximally before treatment with thyroxine was begun.
DR. FREDRIC COE (Director, University of Chicago Renal
Services, Michael Reese Hospital, Chicago): Dr. Jamison, I am
interested in your thoughts about the persistent thirst in this
patient. If you or I become sufficiently hyponatremic, our thirst
is blunted and we avoid water. This patient clearly had a
substantial defect of free-water excretion, but it seems to me
that he also must have had something wrong with his thirst
mechanism.
DR. JAMISON: You are correct. We understand better the
defect in water excretion than why patients with hyponatremia
keep drinking. Increased water intake occurs after adrenalecto-
my and may be caused by a fall in extracellular fluid volume and
perhaps by increased renin secretion [36]. It seems reasonable
to suppose that the same thirst receptors stimulated by a decline
in extracellular fluid volume or by hemorrhage are also stimu-
lated by the impaired cardiac output, which occurs in glucocor-
ticoid deficiency. The fact that the serum sodium concentration
returned to normal coincident with the apparent restoration of
his circulation by prednisone (Fig. 6) supports this interpreta-
tion. But why patients with hyponatremia secondary to inap-
propriate secretion of antidiuretic hormone, for example, drink
more than seems appropriate to satiate thirst is not understood
[36].
DR. JORDAN J. COHEN: Occasionally, it is difficult to distin-
guish nephrogenic diabetes insipidus from primary polydipsia.
Patients with primary polydipsia often do not respond normally
to antidiuretic hormone, presumably because of "medullary
wash-out." Could you comment on this problem?
DR. JAMIs0N: The difficulties encountered in distinguishing
primary polydipsia from other causes of polyuria have been
recently demonstrated by Zerbe and Robertson [37]. I would
only emphasize two requirements in carrying out the water
deprivation test: patience and the certainty that the patient has
no access to water. After an adequate stimulus to endogenous
ADH secretion, if the rise in urine osmolality falls short of
plasma osmolality (as was the case in today's patient), one can
be reasonably confident in excluding primary polydipsia. Of
seven patients ultimately proved to have primary polydipsia in
Zerbe's study, one failed to increase the urine osmolality above
that of plasma, not only before but after exogenous ADH
administration [371. That response was so surprising on
clinical grounds that it was repeated with a longer period of
fluid restriction. The second time, urine osmolality rose
above plasma osmolality and did not increase further after
ADH.
Regarding your second comment—about so-called "medul-
lary wash-out' '—it is thought to be the consequence of two
features of water diuresis that are not widely appreciated. First,
in the absence of ADH, water is still reabsorbed across the
entire collecting duct, although considerably less in total vol-
ume than in the presence of ADH [38]. Second, as was
mentioned previously, the principal site of this water reabsorp-
tion is shifted from the "top" of the collecting duct system in
the cortex, where the high blood flow easily accommodates the
water uptake, to the "bottom" of the collecting duct system in
the inner medulla and papilla, where the effective blood flow is
lower [11, 38]. Water is reabsorbed in this region despite the
absence of ADH because of the unusually large transepithelial
osmotic gradients between the hypotonic urine and the hyper-
osmotic renal medulla. The capillary uptake of the extra water
increases vasa recta blood flow, which results in loss of solute,
thus reducing the osmolality of the papilla [7]. Even in extreme
water diuresis, however, the renal papilla remains somewhat
hyperosmotic [38], which is why, during water deprivation,
urine osmolality rises above plasma osmolality in a patient with
primary polydipsia, even though it does not reach values
obtained in normal controls after water deprivation.
DR. JOHN DONOHOE (Consultant Nephrolo gist, Mater Miser-
icordiae Hospital, Dublin, Ireland): Given that the IVP shows
an element of bladder outlet obstruction, would you accept that
there might be a "touch" of acquired nephrogenic DI second-
ary to obstructive nephropathy in this patient?
DR. JAMISON: This patient indeed might have had a "touch"
of resistance to ADH, given the changes that obstruction causes
in the function of the collecting duct. Hanley and Davidson, for
example, showed that after 24 hours of urinary tract obstruc-
tion, there is a marked impairment of ADH-induced water flow
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in the cortical collecting tubule [39]; that is, true "nephrogenic"
diabetes insipidus develops. Several other well-recognized fac-
tors also play a role in the diuresis [7]. The fact remains,
however, that this patient eventually manifested the ability to
respond to antidiuretic hormone appropriately.
DR. JULIA GLYNN (Medical Resident, Michael Reese Hospi-
tal): A great deal has been written in the past few years about
the effect of prostaglandins on urinary dilution. How important
are these effects?
DR. JAMIs0N: Prostaglandins are unsaturated fatty acids
synthesized intensively in the renal medulla. The ratio of
prostaglandin synthetase activities among papilla, outer medul-
la, and cortex in rat and rabbit is 100:10:1 [401. Within the
medulla, prostaglandins are synthesized in both the collecting
tubule and the interstitial cell. Prostaglandins produced in the
collecting tubule cell have been shown to antagonize the action
of ADH. This is intriguing because ADH stimulates the produc-
tion of prostaglandin, and suggests a negative feedback loop
that I think will probably turn out to be important physiological-
ly. Prostaglandins also have well-known vasomotor effects in
the kidney [41]. The predominant prostaglandin produced in the
medulla, PGE2, is a powerful vasodilator. It is tempting to
speculate that PGE2 produced in the interstitial cell might
influence the medullary circulation. In my laboratory, Kevin
Lemley has shown that the administration of prostaglandin
inhibitors reduces the flow of red blood cells in the vasa recta
[42]. Such an action would reduce solute loss from the medul-
lary interstitium by way of the ascending vasa recta and thereby
enhance medullary hypertonicity and urinary concentrating
ability. In short, pro staglandins appear to antagonize the antidi-
uretic action of ADH and to increase medullary blood flow;
both actions would facilitate the excretion of dilute urine.
DR. FRANCIS MULDOWNEY (St. Vincent's Hospital, Dublin):
This patient had a pulmonary cancer and had been taking
thiazides for years. These facts raise the possibility that he was
hypercalcemic at the time of his first admission. Could hyper-
calcemia have accounted, at least in part, for the polyuria and
polydipsia?
DR. JAMIs0N: Although hypercalcemia is known to cause
polyuria by several mechanisms including impaired response to
ADH [7], it rarely produces a true diabetes insipidus picture,
that is, the excretion of urine hypotonic to plasma. Moreover,
the patient could identify the precise day, and even the hour,
when his polyuria began, which is a history characteristic of the
acquired form of central diabetes insipidus. Finally, there is no
evidence that the patient ever had hypercalcemia.
DR. JOHN T. HARRINGTON: Dr. Jamison, I'd like to turn from
a salt and water discussion to the interesting acid-base problem
in this patient, The typical patient with hyponatremia due to
SIADH has a plasma bicarbonate that is virtually normal,
whereas the patient with hyponatremia due to adrenal insuffi-
ciency often has a plasma bicarbonate concentration less than
20 mEq/liter. This patient's plasma bicarbonate concentration
of 22 mEq/liter (during the first admission) is sort of "halfway"
between. How do you explain his bicarbonate value?
DR. JAM ISON: The plasma bicarbonate was indeed low and
had fallen from 28 mEq/liter recorded earlier at the other
hospital. I do not think this was due to adrenal cortical
insufficiency because, as I mentioned, it is likely that he was
deficient only in glucocorticoid and not mineralocorticoid. In
any case, a mineralocorticoid deficiency would have led to a
metabolic acidosis, but he did not have an acidosis. Arterial
blood gases on admission were: pH, 7.44; HCO3, 22 mEq/liter;
PCO2, 33 TORR; and P02, 66 TORR. What do you think
accounts for the low plasma bicarbonate, Dr. Harrington?
DR. HARRINGTON: I agree that he did not have a total
deficiency of mineralocorticoid and I suspect that that is why
his plasma bicarbonate concentration was not substantially
lower. In this patient, however, there is no possibility of excess
ADH and I suspect that the depressed plasma bicarbonate
concentration was a consequence of hypocapnia due to the
large quantity of salicylates that the patient consumed in the
few days before admission. The pH of 7.44 is certainly consist-
ent with respiratory alkalosis as part of his acid-base disorder.
DR. PATRICK VINAY (University of Montreal, Montreal,
Canada): Is it possible that angiotensin excess was involved in
any way in the polyuria in this patient?
DR. JAMISON: I suppose it is possible that the patient's
angiotensin level was high and that it stimulated him to drink
water. It has been reported that angiotensin, particularly when
infused into the carotid artery, stimulates drinking [43]. But
there is no evidence that the plasma angiotensin was high in this
patient.
DR. DAVID BUSHINSKY (Renal Service, Michael Reese Hos-
pital).' I was surprised to hear that you attributed the dysphasia
to hyponatremia per se. Usually we think of hyponatremia as
causing a global rather than a focal alteration in CNS function.
Moreover, serum sodium concentrations are usually lower than
in this patient when CNS dysfunction occurs. Could you review
the evidence for the causal link between dysphasia and
hyponatremia?
DR. JAMISON: A neurologist who examined the patient during
and after the acute episode of fluent aphasia noted that it
coincided with the low serum sodium concentration of 123
mEq/liter and suggested that the episode of aphasia was afocal
manifestation of hyponatremia, probably reflecting metastatic
foci in the dominant cerebral hemisphere. The use of DDAVP
was discontinued for 24 hours with resolution of the patient's
aphasia and a return of the serum sodium concentration to
normal. Thus the hypothetical link between an acute change in
the serum sodium concentration and the dysphasia is the
metastases in that region of the brain where lesions produce a
fluent aphasia. The neurologist was suggesting, I believe, that
the speech defect was caused by hyponatremia-induced cell
swelling, either of the normal cells remaining in the "speech
region" of the brain, or the tumor cells, or both. There being no
other obvious explanation for the transient speech disturbances
in this patient, I thought it was an intriguing suggestion.
DR. NIC0LA0s E. MADIAS: I believe that urinary prostaglan-
din levels are decreased in the Brattleboro rat. Have such
measurements been made in patients with central diabetes
insipidus and, if so, how do you interpret their significance?
DR. JAMIs0N: The Brattleboro rat with hypothalamic diabe-
tes insipidus does excrete substantially less prostaglandins than
do normal rats [44]. I am not aware of reports of similar
measurements in patients with diabetes insipidus. Underpro-
duction of prostaglandins would be expected to ameliorate the
polyuria due to vasopressin deficiency, as we talked about
before.
DR. CHARLES E. MCCOY (Medical Resident, Michael Reese
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Hospital): This patient was given a dose of prednisone that
clearly exceeded physiologic replacement requirements. Could
the glucocorticoid excess, with its potential for mineralocor-
ticoid activity, interfere with the interpretation of the hormonal
tests?
DR. JAMISON: Yes, to the extent the patient might have had
an underlying mineralocorticoid deficiency in addition to his
documented glucocorticoid deficiency, it would be difficult for
us to conclude that the impaired ability to excrete water was
due exclusively to the lack of glucocorticoid. If I were in the
shoes of the physician caring for the patient at the time,
however, I might not have quibbled about the dose, even
though a consultant did suggest it was not necessary to give as
much prednisone as he received. All the evidence pointed to
secondary adrenocortical insufficiency, in which aldosterone
secretion is near normal.
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